Konica Minolta Launches Exa Teleradiology Platform
The cloud-based platform reportedly facilitates AI-enhanced teleradiology workflow efficiencies across multiple systems and facilities.
Offering a variety of tools to foster increased efficiency and imaging quality for remote radiologists, Konica Minolta has unveiled the cloud-based Exa Teleradiology system.
Developed in collaboration with the NewVue, the Exa Teleradiology platform reduces manual tasks with automated curation of worklists through the artificial intelligence (AI) powered Radiology Workflow Orchestrator, according to Konica Minolta.
Key attributes of the cloud-based Exa Teleradiology platform include the AI-powered Radiology Workflow Orchestrator and the Exa Teleradiology Viewer, which enables 3D-generated segmentation and reconstruction of images for teleradiologists. (Image courtesy of Konica Minolta.)
The company said another key attribute is the Exa Teleradiology Viewer, which enables server-side rendering of images as well as 3D-generated segmentation and reconstruction of images for teleradiologists.
“In partnership with NewVue, we will deliver an expanded, cloud-first imaging solution that is built to meet the demands of modern teleradiology with unmatched workflow orchestration, performance and clinical value,” said Kevin Chlopecki, the chief operating officer for Konica Minolta Healthcare HCIT.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
